Edge Capital Group, LLC Astrazeneca PLC Transaction History
Edge Capital Group, LLC
- $1.9 Billion
- Q4 2024
A detailed history of Edge Capital Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Edge Capital Group, LLC holds 143,842 shares of AZN stock, worth $11.1 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
143,842
Previous 144,010
0.12%
Holding current value
$11.1 Million
Previous $11.2 Million
16.01%
% of portfolio
0.5%
Previous 0.51%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,366Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.68 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.18 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.91 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.87 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.86 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...